Advanced Accelerator Applications, a radiopharmaceutical diagnostics company developing its first therapeutic product, refiled on Thursday with the SEC to raise up to $75 million in an initial public offering.
The company originally filed for a $100 million IPO in November 2014 and filed terms to raise $75 million in February 2015, but postponed and withdrew its IPO.
Close peer Lantheus (LNTH), which had also postponed an IPO, came back and priced a $65 million offering in June 2015, but now trades 21% below the offer price.
The Saint Genis Pouilly, France-based company, which was founded in 2002 and booked $89 million in sales for the 12 months ended June 30, 2015, plans to list on the Nasdaq under the symbol AAAP. Advanced Accelerator Applications filed confidentially on August 21, 2015. Citi and Jefferies are the joint bookrunners on the deal. No pricing terms were disclosed.
